4
LABinnovatorLABinnovator
COMPANYEVENTSPAST EVENTSPARTNERSCAREERSCONTACT

Freedom To Operate

Maximising your licensing strategy to avoid patent infringements in the life science industry

Date: May 27, 2008
Venue:  Radisson SAS Scandinavia Hotel
City: Copenhagen, Denmark

In the chair:

Anette Hegner IP Manager

NKT HOLDING

Hear from your eminent Speaker Panel:

Lars Bo Kjerrumgaard Head of Corporate Patents

H. LUNDBECK

Birgitte Stephensen Director Intellectual Property

GENMAB

Vincent Lannoy Business Development & Licensing Manager

EUROSCREEN SA

Dr. Ashley J. Stevens Director Office of Technology Transfer

BOSTONUNIVERSITY (USA)

Steen Parsholt Senior Advisor

PLOUGMANN & VINGTOFT

Kim Wagner European Patent Attorney, Partner

PLOUGMANN & VINGTOFT

Sofia Nikolopoulou, Patent Attorne

ZACCO

 

Event Summary:

In the life science industry, there is a shift from patent protection to freedom to operate, which opens up opportunities for collaboration and licensing with other companies. A freedom to operate search for critical patents is the first step to identify available targets before starting a new R & D project.

Intellectual property is the cornerstone to early-stage deal making in the life science industry and by owning, or to have exclusive rights to a key patent or a patent, a company are able to exclude its chief competitors from the marketplace. Once a target is identified the FTO strategy enable companies to successfully start collaboration or to make licensing deals to maximise the commercial success.

This flagship event will present best examples to capitalise on freedom to operate to successfully commercialise scientific discoveries in the global life science industry. Our distinguished speaker panel will guide you through from the early stage freedom to operate search to set up an FTO strategy to collaborate and make licensing deals with partners and competitors. By attending this high level one day-conference your company will be able to boost the patent potential through partnerships in a competitive business environment, the life science industry.

This conference will tackle key issues such as:

  • Maximising around licensing strategies to avoid patent infringements in the life science industry
  • Building in-house competence to master your freedom to operate strategies
  • Designing an FTO strategy through co-operation between R & D, patent and marketing functions in your organisation
  • Examining current status and future freedom to operate trends in the life science industry
  • Developing IP strategies to secure your patents in a global marketplace
  • Mastering an FTO strategy to reduce risks through licensing and deal making with your competitors
  • Capitalising on IPR strategy to move R & D projects to claim patents on your scientific discoveries
  • Building patent portfolios to maximise the value of your IP

Target audience and Job titles:

Presidents, Chief Executive Officers, Chief IP Counsels, Chief Scientific Officers, Vice Presidents, Directors and Heads within:

  • Licensing
  • IPR Strategy
  • Legal and Intellectual Property
  • Global Intellectual Property
  • Patents
  • Intellectual Property Rights
  • IP Licensing Strategy
  • Patents - Biotechnology
  • Corporate Patents and Business Development
  • Intellectual Property
  • Pharmaceutical Patents
  • Corporate Intellectual Property
  • Research & Development
  • Business Development
  • European Patent Attorneys
  • Venture Capitalists
  • Patent Attorneys
  • Patent agents
  • Scientists

 

 
LABinnovator